Showing 7,462 news articles about Health services & systems

Filters Content type: Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

New & experimental hepatitis C treatment

Gilead, Abbott Unwrap Dueling Hep C Pill Data

Editor's pick
The Street
12 November 2012
Access to healthcare

Study shows drug patents can be extended for decades

Editor's pick
Intellectual Property Watch
12 November 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim to start late-stage hepatitis C drug trial

Editor's pick
Reuters
11 November 2012
New & experimental hepatitis C treatment

Idenix Reports On IDX719 and IDX184

Editor's pick
Idenix press release
11 November 2012
PrEP

(PrEP) The ANRS-IPERGAY study should be discontinued : prevention research in France is in disarray

Editor's pick
The Warning
9 November 2012
Improving HIV care

South Africa: Private Sector Funding to Train Doctors

Editor's pick
AllAfrica
9 November 2012
Government, leadership & policy

The AIDS Institute On 2012 Election Results - Congratulates President Obama & Encourages Him to Continue to Implement National HIV/AIDS Strategy

Editor's pick
The AIDS Institute press release
8 November 2012
Finance & funding

Global Fund Invites Myanmar To Apply For Additional Funding

Editor's pick
Kaiser Daily Global Health Policy Report
8 November 2012
Finance & funding

Activists want Brazil government to drop proposed new AIDS funding rule

Editor's pick
aidspan
8 November 2012
Pharmaceutical industry

Drugmakers offer to cap Greece's medicines bill

Editor's pick
Reuters
8 November 2012
Pharmaceutical industry

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

Editor's pick
The Pharma Letter
8 November 2012
Epidemiology

Angola: Country to Keep HIV/Aids Prevalence Lower Than Three Per Cent Until 2015

Editor's pick
AllAfrica
7 November 2012
Circumcision

UGANDA: Mixed progress in male circumcision campaign

Editor's pick
IRIN Plus News
6 November 2012
New & experimental hepatitis C treatment

Copy of Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
New & experimental hepatitis C treatment

Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
Pharmaceutical industry

Drugmakers offer to cap Greece's medicines bill

Editor's pick
Reuters
6 November 2012
Access to healthcare

SOUTH AFRICA: Easy patents cost patients

Editor's pick
IRIN Plus News
6 November 2012
Global health initiatives

How can the HIV community shape the future HIV and development agenda?

Editor's pick
International HIV/AIDS Alliance
5 November 2012
Pharmaceutical industry

Gilead and the Pharmasset Deal: Do the Ends Justify the Means?

Editor's pick
PropThink
5 November 2012
Cancer

Cancer doctors pledge to take prevention and treatment to the poor

Editor's pick
The Guardian
5 November 2012
Access to healthcare

Hope for hep-c patients: Patients succeed in overturning first ever product patent on medicine in India

Editor's pick
Lawyers' Collective
2 November 2012
Access to healthcare

IPAB revokes patent on Roche Hepatitis C drug

Editor's pick
Hindu Business Line
2 November 2012
New & experimental hepatitis C treatment

Vertex Joins Glaxo, J&J in Testing Hepatitis C Combos

Editor's pick
Bloomberg BusinessWeek
1 November 2012
New & experimental HIV treatments

Gilead: HIV drug meets key Phase 2 trial objective

Editor's pick
Gilead press release
31 October 2012